Moon Karam, Levitt Michael R, Almefty Rami O, Nakaji Peter, Albuquerque Felipe C, Zabramski Joseph M, McDougall Cameron G, Spetzler Robert F
Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Neurosurgery. 2015 Oct;77(4):566-71; discussion 571. doi: 10.1227/NEU.0000000000000878.
Ruptured anterior communicating artery (ACoA) aneurysms are heterogeneous intracranial aneurysms whose diverse morphological features influence treatment modality.
To compare clinical outcomes and complications of all ruptured ACoA aneurysms treated by clipping or coiling in a modern institutional trial.
All patients with ruptured ACoA aneurysms in the Barrow Ruptured Aneurysm Trial were included. Clinical follow-up at 1 and 3 years was analyzed; charts were reviewed for patient demographics, aneurysm characteristics, and in-hospital complications.
This cohort included 130 patients (mean age, 52.5 years). Mean aneurysm size was 5.8 mm. Most aneurysm domes projected anteriorly (n = 52). After randomization and crossover, 91 ACoA aneurysms (70%) were clipped and 39 (30%) were coiled. Twenty-two patients (16.9%) initially randomized to coiling crossed over to clipping after evaluation. No patients crossed over from clipping to coiling. Characteristics precluding aneurysms from coiling included unfavorable dome-to-neck ratio, lesions difficult to access by catheter, and branch vessel involvement. Aneurysm size and dome projection were not significantly associated with treatment group, clinical outcome, or retreatment. No significant difference existed in clinical outcome (modified Rankin Scale scores) between groups at discharge or at 1-year or 3-year follow-up using as-treated and intention-to-treat analyses. Retreatment was performed in 3 clipped patients (2.3%) and 3 coiled patients (2.3%).
Ruptured ACoA aneurysms, regardless of size and projection, were safely treated by both treatment modalities in a large-scale randomized clinical trial. Clinical outcomes and stroke rates did not differ significantly in as-treated or intention-to-treat analyses.
破裂的前交通动脉(ACoA)动脉瘤是异质性颅内动脉瘤,其多样的形态特征会影响治疗方式。
在一项现代机构试验中比较所有通过夹闭或栓塞治疗的破裂ACoA动脉瘤的临床结局和并发症。
纳入巴罗破裂动脉瘤试验中所有破裂ACoA动脉瘤患者。分析1年和3年的临床随访情况;查阅病历以了解患者人口统计学信息、动脉瘤特征和院内并发症。
该队列包括130例患者(平均年龄52.5岁)。动脉瘤平均大小为5.8mm。大多数动脉瘤瘤顶向前突出(n = 52)。随机分组和交叉后,91个ACoA动脉瘤(70%)接受夹闭治疗,39个(30%)接受栓塞治疗。22例最初随机分组至栓塞治疗的患者在评估后交叉至夹闭治疗。没有患者从夹闭治疗交叉至栓塞治疗。排除动脉瘤进行栓塞治疗的特征包括瘤颈比不理想、导管难以到达的病变以及分支血管受累。动脉瘤大小和瘤顶突出与治疗组、临床结局或再次治疗无显著相关性。在出院时、1年或3年随访时,采用实际治疗分析和意向性分析,两组间临床结局(改良Rankin量表评分)无显著差异。3例接受夹闭治疗的患者(2.3%)和3例接受栓塞治疗的患者(2.3%)进行了再次治疗。
在一项大规模随机临床试验中,无论大小和突出情况如何,破裂的ACoA动脉瘤通过两种治疗方式均可安全治疗。实际治疗分析或意向性分析中,临床结局和卒中发生率无显著差异。